CRONaxal is a Patented Medical Food for the dietary management of Glial Tumors. It can be combined with chemotherapy, radiation, calorie restriction, and holistic approaches.
CRONaxal contains oxaloacetate, a US FDA designated "Orphan Drug" for Glial Tumors (12-3704)
CRONaxal is formulated for Patients with:
- Glioblastoma Multiforme
Note: International orders may be subject to local import duties and fees.